Skip to main content
. 2023 Mar 13;11:e15025. doi: 10.7717/peerj.15025

Table 4. Clinicopathologic characteristics according to biochemical cure.

Variables Biochemical cure P value
Total Yes No
Age (years) 0.237
≤50 68 (49.3) 38 (45.2) 30 (55.6)
>50 70 (50.7) 46 (54.8) 24 (44.4)
Gender 0.215
Male 60 (43.5) 33 (39.3) 27 (50.0)
Female 78 (56.5) 51 (60.7) 27 (50.0)
Tumor size (cm) 0.198
≤2 cm 98 (71.0) 63 (75.0) 35 (64.8)
>2 cm 40 (29.0) 21 (25.0) 19 (35.2)
Multifocality 0.030
Yes 37 (26.8) 17 (20.2) 20 (37.0)
No 101 (73.2) 67 (79.8) 34 (63.0)
Extrathyroidal extension 0.242
Yes 53 (38.4) 29 (34.5) 24 (44.4)
No 85 (61.6) 55 (65.5) 30 (55.6)
Bilateral 0.082
Yes 10 (7.2) 3 (3.6) 7 (13.0)
No 128 (92.8) 81 (96.4) 47 (87.0)
Pathologic T classification 0.096
pT1/T2 81 (58.7) 54 (64.3) 27 (50.0)
pT3/T4 57 (41.3) 30 (35.7) 27 (50.0)
Preoperative calcitonin 0.001
≤300 ng/L 51 (37.0) 40 (47.6) 11 (20.4)
>300 ng/L 87 (63.0) 44 (52.4) 43 (79.6)
Pathologic N classification <0.001
pN0 60 (43.5) 51 (60.7) 9 (16.7)
pN1a 21 (15.2) 12 (14.3) 9 (16.7)
pN1b 57 (41.3) 21 (25.0) 36 (66.7)
Resected lymph nodes <0.001
≤10 65 (47.1) 51 (60.7) 14 (25.9)
>10 73 (52.9) 33 (39.3) 40 (74.1)
Metastasized lymph nodes <0.001
≤10 118 (85.5) 80 (95.2) 38 (70.4)
>10 20 (14.5) 4 (4.8) 16 (29.6)
Lymph node ratio <0.001
≤0.24 73 (57.9) 58 (76.3) 15 (30.0)
>0.24 53 (42.1) 18 (23.7) 35 (70.0)
AJCC clinical stage <0.001
I/II 54 (39.1) 48 (57.1) 6 (11.1)
III/IV 84 (60.9) 36 (42.9) 48 (88.9)
Recurrence 0.002
Yes 20 (14.5) 6 (7.1) 14 (25.9)
No 118 (85.5) 78 (92.9) 40 (74.1)
Death 0.711
Yes 8 (5.8) 4 (4.8) 4 (7.5)
No 129 (94.2) 80 (95.2) 49 (92.5)

Note:

The bold part of the P value represents P < 0.05.